SCHEMBL677206

SCHEMBL677206

CCCCCCCC/C=C/CCCCCCCC1=NC(C)(C)CO1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.39
FAAH O00519 2/20 0.38
TRPV1 Q8NER1 1/20 0.38
CDC25A P30304 1/20 0.37
CDC25B P30305 1/20 0.37
CDC25C P30307 1/20 0.37
ALDH1A1 P00352 1/20 0.35
TSHR P16473 1/20 0.35
MEN1 O00255 1/20 0.35
CYP3A4 P08684 1/20 0.35
KMT2A Q03164 1/20 0.35
GMNN O75496 1/20 0.34
USP2 O75604 1/20 0.34
LMNA P02545 1/20 0.34
CYP1A2 P05177 1/20 0.34
POLB P06746 1/20 0.34
MAPT P10636 1/20 0.34
CYP2C9 P11712 1/20 0.34
ALOX15 P16050 1/20 0.34
APEX1 P27695 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL677207 1.00 EPHX2 (0.39) EPHX2FAAHTRPV1CDC25ACDC25B
SCHEMBL23198744 0.96 TRPV1 (0.39) FAAHTRPV1ALDH1A1TSHRCYP3A4
SCHEMBL10616726 0.90 LPL (0.33) ALDH1A1TSHR
SCHEMBL9788005 0.90 LPL (0.33) ALDH1A1TSHR
SCHEMBL9787882 0.90 LPL (0.33) ALDH1A1TSHR
SCHEMBL9787850 0.90 LPL (0.33) ALDH1A1TSHR
SCHEMBL10491816 0.90 LPL (0.33) ALDH1A1TSHR
SCHEMBL9787963 0.88 KDM4E (0.34)
SCHEMBL8988091 0.86 FFAR1 (0.49) EPHX2FAAHTRPV1ALDH1A1MEN1
SCHEMBL677125 0.82 EPHX2 (0.38) EPHX2CDC25ACDC25BCDC25C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 176 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220249446-A1 Composition Comprising at Least One Oxazoline for Inhibiting the Growth of Malassezia Yeasts Involved in Cradle Cap, in Particular LABORATOIRES EXPANSCIENCE (FR) 2022-08-11 US claimed
EP-3996674-A1 COMPOSITION COMPRISING AT LEAST ONE OXAZOLINE FOR INHIBITING THE GROWTH OF MALASSEZIA YEASTS INVOLVED IN CRADLE CAP, IN PARTICULAR Laboratoires Expanscience (FR) 2022-05-18 EP claimed
EP-2953611-B1 USE OF A COMPOSITION COMPRISING AVOCADO PERSEOSE IN THE PROTECTION OF EPIDERMAL STEM CELLS EXPANSCIENCE LAB (FR) 2021-08-18 EP claimed
WO-2021009142-A1 COMPOSITION COMPRISING AT LEAST ONE OXAZOLINE FOR INHIBITING THE GROWTH OF MALASSEZIA YEASTS INVOLVED IN CRADLE CAP, IN PARTICULAR LABORATOIRES EXPANSCIENCE (FR) 2021-01-21 WO claimed
US-20200085897-A1 Extract of Aerial Parts of Maca Rich in Polyphenols and Composition Comprising Same LABORATOIRES EXPANSCIENCE (FR) 2020-03-19 US claimed
EP-2654765-B1 EXTRACT OF THE AERIAL PARTS OF MACA RICH IN POLYPHENOL AND COMPOSITION COMPRISING THE EXTRACT EXPANSCIENCE LAB (FR) 2019-03-13 EP claimed
EP-2654766-B1 EXTRACT OF THE PULP AND/OR PEEL OF AVOCADO RICH IN POLYPHENOLS AND COSMETIC, DERMATOLOGIC OR NUTRACEUTIC COMPOSITIONS COMPRISING THEREOF EXPANSCIENCE LAB (FR) 2018-10-10 EP claimed
EP-2654762-B1 EXTRACT OF THE AERIAL PARTS OF GYNANDROPSIS GYNANDRA AND COSMETIC, DERMATOLIGIC AND PHARMACEUTIC COMPOSITIONS COMPRISING THE EXTRACT EXPANSCIENCE LAB (FR) 2018-09-26 EP claimed
US-20150374605-A1 USE OF A COMPOSITION COMPRISING AVOCADO PERSEOSE IN THE PROTECTION OF EPIDERMAL STEM CELLS LABORATOIRES EXPANSCIENCE (FR) 2015-12-31 US claimed
EP-2953611-A1 USE OF A COMPOSITION COMPRISING AVOCADO PERSEOSE IN THE PROTECTION OF EPIDERMAL STEM CELLS Laboratoires Expanscience (FR) 2015-12-16 EP claimed
EP-1874410-B1 DEPIGMENTING OR BRIGHTENING COSMETIC COMPOSITION COMPRISING AT LEAST ONE OXAZOLIN AS AN ACTIVE INGREDIENT EXPANSCIENCE LAB (FR) 2009-03-11 EP claimed
EP-1874410-A1 DEPIGMENTING OR BRIGHTENING COSMETIC COMPOSITION COMPRISING AT LEAST ONE OXAZOLIN AS AN ACTIVE INGREDIENT Laboratoires Expanscience (FR) 2008-01-09 EP claimed
EP-1648569-B1 COSMETIC USE OF A COMPOSITION CONTAINING AT LEAST ONE OXAZOLINE, SERVING AS AN ACTIVE SUBSTANCE, AS A SLIMMING PRODUCT AND/OR FOR PREVENTING AND/OR TREATING CELLULITE EXPANSCIENCE LAB (FR) 2006-12-06 EP claimed
WO-2006114443-A1 DEPIGMENTING OR BRIGHTENING COSMETIC COMPOSITION COMPRISING AT LEAST ONE OXAZOLIN AS AN ACTIVE INGREDIENT LABORATOIRES EXPANSCIENCE (FR) 2006-11-02 WO claimed
US-20060122246-A1 Cosmetic use of a composition containing at least one oxazoline, serving as an active substance, as a slimming product and/or for preventing and/or treating cellulite LABORATOIRES EXPANSCIENCE 2006-06-08 US claimed
EP-1648569-A1 COSMETIC USE OF A COMPOSITION CONTAINING AT LEAST ONE OXAZOLINE, SERVING AS AN ACTIVE SUBSTANCE, AS A SLIMMING PRODUCT AND/OR FOR PREVENTING AND/OR TREATING CELLULITE Laboratoires Expanscience (FR) 2006-04-26 EP claimed
US-20050075380-A1 Composition comprising at least one oxazolin for inhibiting langerhans cell migratio, and uses thereof LABORATOIRES EXPANSCIENCE (FR) 2005-04-07 US claimed
WO-2004112741-A1 COSMETIC USE OF A COMPOSITION CONTAINING AT LEAST ONE OXAZOLINE, SERVING AS AN ACTIVE SUBSTANCE, AS A SLIMMING PRODUCT AND/OR FOR PREVENTING AND/OR TREATING CELLULITE LABORATOIRES EXPANSCIENCE (FR) 2004-12-29 WO claimed
EP-1458349-A1 COMPOSITION COMPRISING AT LEAST AN OXAZOLIN FOR INHIBITING LANGERHANS CELL MIGRATION, AND USES THEREOF Laboratoires Expanscience (FR) 2004-09-22 EP claimed
WO-2003055463-A1 COMPOSITION COMPRISING AT LEAST AN OXAZOLIN FOR INHIBITING LANGERHANS CELL MIGRATION, AND USES THEREOF LABORATOIRES EXPANSCIENCE (FR) 2003-07-10 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220249446-A1 Composition Comprising at Least One Oxazoline for Inhibiting the Growth of Malassezia Yeasts Involved in Cradle Cap, in Particular OCIAD1, ERG28, CYP51A1 EPHX2 2413/4885FAAH 577/4885TRPV1 3184/4885
US-20050075380-A1 Composition comprising at least one oxazolin for inhibiting langerhans cell migratio, and uses thereof MIF, CUTA, ARG1 EPHX2 1978/4885FAAH 121/4885TRPV1 25/4885
US-20150374605-A1 USE OF A COMPOSITION COMPRISING AVOCADO PERSEOSE IN THE PROTECTION OF EPIDERMAL STEM CELLS HES1, PRUNE1, DSG1 EPHX2 1241/4885FAAH 1297/4885TRPV1 2977/4885
US-20060122246-A1 Cosmetic use of a composition containing at least one oxazoline, serving as an active substance, as a slimming product and/or for preventing and/or treating cellulite CUTA, SYMPK, LPXN EPHX2 2157/4885FAAH 599/4885TRPV1 1797/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.